[go: up one dir, main page]

ES2001013A6 - Un metodo para la preparacion de anticuerpos especificos de histamina - Google Patents

Un metodo para la preparacion de anticuerpos especificos de histamina

Info

Publication number
ES2001013A6
ES2001013A6 ES8600092A ES8600092A ES2001013A6 ES 2001013 A6 ES2001013 A6 ES 2001013A6 ES 8600092 A ES8600092 A ES 8600092A ES 8600092 A ES8600092 A ES 8600092A ES 2001013 A6 ES2001013 A6 ES 2001013A6
Authority
ES
Spain
Prior art keywords
histamine
preparation
specific antibodies
antibodies
immunogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8600092A
Other languages
English (en)
Inventor
Robert T Bucker
Frank A Dailey
John A Ficalora
John J Gavin
Gregory A Plunkett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Laboratories Inc filed Critical Miles Laboratories Inc
Publication of ES2001013A6 publication Critical patent/ES2001013A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Luminescent Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

UN METODO PARA LA PREPARACION DE ANTICUERPOS ESPECIFICOS DE HISTAMINA. SE DESCRIBEN DERIVADOS DE HISTAMINA, CONJUGADOS INMUNOGENOS QUE COMPRENDEN HISTAMINA O LOS CITADOS DERIVADOS DE HISTAMINA ACOPLADOS A MATERIALES PORTADORES INMUNOGENICOS Y ANTICUERPOS PREPARADOS CONTRA DICHOS CONJUGADOS INMUNOGENOS. ESTOS ANTICUERPOS SON UTILES EN INMUNOENSAYOS PARA DETERMINAR LA LIBERACION DE HISTAMINA EN FLUIDOS BIOLOGICOS.
ES8600092A 1985-07-03 1986-07-02 Un metodo para la preparacion de anticuerpos especificos de histamina Expired ES2001013A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75232085A 1985-07-03 1985-07-03

Publications (1)

Publication Number Publication Date
ES2001013A6 true ES2001013A6 (es) 1988-04-16

Family

ID=25025799

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8600092A Expired ES2001013A6 (es) 1985-07-03 1986-07-02 Un metodo para la preparacion de anticuerpos especificos de histamina

Country Status (12)

Country Link
EP (1) EP0208953B1 (es)
JP (1) JPS6210070A (es)
AT (1) ATE52251T1 (es)
AU (1) AU576088B2 (es)
CA (1) CA1302919C (es)
DE (1) DE3670632D1 (es)
DK (2) DK172086B1 (es)
ES (1) ES2001013A6 (es)
FI (1) FI86145C (es)
IE (1) IE58544B1 (es)
NO (1) NO168746C (es)
ZA (1) ZA862620B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2562671B1 (fr) * 1984-04-10 1986-07-25 Immunotech Sa Procede pour le dosage immunologique des monoamines
US4996221A (en) * 1987-01-13 1991-02-26 The Board Of Trustees Of The Leland Stanford Junior University Histamine derivatives as immune modulators
CA2000177A1 (en) * 1988-10-13 1990-04-13 Ronald E. Wyrick Predicting sensitivity to injectable radio contrast media with a histamine release test
ATE161852T1 (de) * 1989-03-14 1998-01-15 Univ Nebraska Monoklonale antikörper für metall kationen
WO1993014753A1 (en) * 1992-01-27 1993-08-05 The Board Of Trustees Of The Leland Stanford Junior University Histamine derivatives and methods for their use
CA2730015C (en) * 2008-07-09 2018-05-01 The Institute For Ethnomedicine Immunoassay for detection of neurotoxic amino acid associated with neurological disorders
EP3752838B1 (de) 2018-02-16 2022-08-03 Frost Diagnostika GmbH Methode zur bestimmung der totalen histamin-abbaukapazität in biologischen proben
CN112695016A (zh) * 2021-01-26 2021-04-23 江南大学 一株分泌组胺单克隆抗体杂交瘤细胞株及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996344A (en) * 1972-05-15 1976-12-07 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies and use
US3988430A (en) * 1975-02-10 1976-10-26 Hoffmann-La Roche Inc. Immunoassay of antipyrine
IE46910B1 (en) * 1977-06-01 1983-11-02 Merck & Co Inc Fluorinated alkylamines and process for preparing same
US4315095A (en) * 1977-07-28 1982-02-09 Merrell Toraude Et Compagnie α-Halomethyl derivatives of amino acids
ZA785435B (en) * 1977-10-19 1979-09-26 Merrell Toraude & Co A-halomethyl derivatives of histamine and related compounds
CA1142466A (en) * 1979-01-09 1983-03-08 Cesar Milstein Cell lines
US4375972A (en) * 1979-10-17 1983-03-08 Allied Corporation Heterogeneous chemiluminescent immunoassays utilizing metallo porphyrin tag
US4722903A (en) * 1983-11-14 1988-02-02 New York Blood Center, Inc. Monoclonal antibodies specific to in vivo fragments derived from human fibrinogen, human fiberin I or human fibrin II
SE8500340L (sv) * 1985-01-24 1986-07-25 Pharmacia Ab Antikroppspreparation samt sett att framstella och sett att anvenda densamma
SE8500339L (sv) * 1985-01-24 1986-07-25 Pharmacia Ab Berarbundet histamin, dess framstellning och anvendning

Also Published As

Publication number Publication date
DK172086B1 (da) 1997-10-20
IE861787L (en) 1987-01-03
IE58544B1 (en) 1993-10-06
CA1302919C (en) 1992-06-09
NO862430D0 (no) 1986-06-18
DK101196A (da) 1996-09-17
FI86145C (fi) 1992-07-27
FI86145B (fi) 1992-04-15
DK314886D0 (da) 1986-07-02
ZA862620B (en) 1986-12-30
ATE52251T1 (de) 1990-05-15
DE3670632D1 (de) 1990-05-31
FI862802A (fi) 1987-01-04
AU576088B2 (en) 1988-08-11
FI862802A0 (fi) 1986-07-01
EP0208953B1 (en) 1990-04-25
DK314886A (da) 1987-01-04
JPS6210070A (ja) 1987-01-19
NO168746C (no) 1992-04-01
EP0208953A1 (en) 1987-01-21
AU5944286A (en) 1987-04-02
DK172410B1 (da) 1998-05-25
NO862430L (no) 1987-01-05
NO168746B (no) 1991-12-23

Similar Documents

Publication Publication Date Title
ES2093778T3 (es) Nuevos anticuerpos y metodos para su uso.
SE8202012L (sv) Humaninterferon-beslektade peptider, antigener, antikroppar och forfarande for framstellning derav
ES2045216T3 (es) Inmunoensayo y derivados polimeros de igg para la compensacion de factores de perturbacion en el inmunoensayo.
BR8604196A (pt) Suspensao de cimento hidraulico para uso na cimentacao de pocos petroliferos
ES2153444T3 (es) Anticuerpos contra interleucina-4 mamifera, y peptidos utiles como antigenos en su produccion.
SE8600998D0 (sv) Parenterala fenytoinpreparat
AU554345B2 (en) Tricyclic antidepressant drug immunogens, antibodies labelled conjugates, and related derivatives
AU570405B2 (en) Conjugates of muramyl-peptides and haptenes
ES2064438T3 (es) Materiales de transferencia termica de colorantes.
BR8506817A (pt) Glicoproteina antigenica bovina,anticorpo relacionado e uso na deteccao de gravidez no gado
ES2001013A6 (es) Un metodo para la preparacion de anticuerpos especificos de histamina
DE3668168D1 (de) Desmosinderivate und reagenz zur herstellung artifizieller antigene.
DE3667996D1 (de) Farbige siliconmassen.
ATE193534T1 (de) Benzodiazepin-derivate sowie deren konjugate mit proteinen und polypeptiden
FI890603L (fi) Menetelmä HIV-hiukkasimmunogeenin ja sen vasta-aineen valmistamiseksi
ES2046187T3 (es) Anticuerpos para uso en la determinacion de la glucoalbumina humana.
ES2058113T3 (es) Metodo de preparacion y uso de antigenos de virus de leucemia felina.
DK439086A (da) Fremgangsmaader til anvendelse af cellelinier, der mangler humane klasseii histokompatibilitetsantigener
EP0248147A3 (en) Method of determining the presence of cancer cells
DE3682105D1 (de) Probe, tracers, immunogene und antikoerper von ethosuximid.
DE3468324D1 (en) Specific antibody to the native form of 2'5'-oligonucleotides, the method of preparation and the use as reagents in immunoassays or for binding 2'5'-oligonucleotides in biological systems
ES2074707T3 (es) Anticuerpos monoclonales que distinguen entre proteinas naturales y proteinas con secuencias modificadas.
FI893333A0 (fi) Menetelmä ja reagenssi vasta-aineiden määrittämiseksi
EP0273754A3 (en) Method of enhancing the biodistribution of antibody for localization in lesions
NO880302D0 (no) Fluorescens-immunoanalyse innbefattende energioverfoering mellom to fluoroforer.